30.18
0.57%
+0.17
Dopo l'orario di chiusura:
30.00
-0.18
-0.60%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$30.01
Aprire:
$30.09
Volume 24 ore:
2.34M
Capitalizzazione di mercato:
$6.27B
Reddito:
$3.97B
Utile/perdita netta:
$-132.00M
Rapporto P/E:
-29.88
EPS:
-1.01
Flusso di cassa netto:
$228.00M
1 W Prestazione:
-2.39%
1M Prestazione:
-6.42%
6M Prestazione:
-2.14%
1 anno Prestazione:
-28.80%
DENTSPLY Sirona Inc Stock (XRAY) Company Profile
Nome
DENTSPLY Sirona Inc
Settore
Industria
Telefono
717-845-7511
Indirizzo
221 West Philadelphia Street, York, NC
DENTSPLY Sirona Inc Stock (XRAY) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2023-11-16 | Iniziato | Needham | Buy |
2023-11-10 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2023-01-12 | Aggiornamento | William Blair | Underperform → Mkt Perform |
2022-08-05 | Downgrade | William Blair | Mkt Perform → Underperform |
2022-06-02 | Aggiornamento | UBS | Neutral → Buy |
2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
2022-04-20 | Downgrade | William Blair | Outperform → Mkt Perform |
2022-04-19 | Downgrade | BofA Securities | Buy → Neutral |
2022-04-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
2022-01-31 | Iniziato | Morgan Stanley | Overweight |
2021-10-01 | Ripresa | Credit Suisse | Outperform |
2021-08-09 | Reiterato | H.C. Wainwright | Neutral |
2021-08-06 | Reiterato | Barrington Research | Outperform |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2021-03-02 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2021-03-02 | Reiterato | H.C. Wainwright | Neutral |
2021-01-05 | Reiterato | H.C. Wainwright | Neutral |
2020-12-18 | Downgrade | Stifel | Buy → Hold |
2020-11-17 | Downgrade | Barclays | Equal Weight → Underweight |
2020-11-09 | Reiterato | H.C. Wainwright | Neutral |
2020-10-22 | Aggiornamento | Guggenheim | Neutral → Buy |
2020-08-10 | Reiterato | H.C. Wainwright | Neutral |
2020-06-16 | Iniziato | Piper Sandler | Overweight |
2020-06-15 | Reiterato | H.C. Wainwright | Neutral |
2020-05-27 | Aggiornamento | Evercore ISI | In-line → Outperform |
2020-05-11 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2020-04-24 | Reiterato | H.C. Wainwright | Neutral |
2020-04-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2020-04-07 | Downgrade | Goldman | Buy → Neutral |
2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2020-03-03 | Reiterato | H.C. Wainwright | Neutral |
2020-02-19 | Reiterato | Stifel | Buy |
2019-12-11 | Downgrade | JP Morgan | Overweight → Neutral |
2019-08-02 | Aggiornamento | Wellington Shields | Hold → Gradually Accumulate |
2019-07-26 | Iniziato | Evercore ISI | In-line |
2019-07-09 | Reiterato | H.C. Wainwright | Neutral |
2019-05-30 | Iniziato | Wolfe Research | Peer Perform |
Mostra tutto
DENTSPLY Sirona Inc Borsa (XRAY) Ultime notizie
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Zacks Investment Research
What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
Zacks Investment Research
Why Dentsply International (XRAY) is a Top Value Stock for the Long-Term
Zacks Investment Research
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts
Benzinga
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
GlobeNewswire Inc.
Here's Why Dentsply International (XRAY) is a Strong Value Stock
Zacks Investment Research
DENTSPLY Sirona Inc Azioni (XRAY) Dati Finanziari
DENTSPLY Sirona Inc (XRAY) Reddito 2024
XRAY ha riportato un ricavo (TTM) di $3.96 miliardi per il trimestre terminato il 2023-12-31, un +1.10% salita anno su anno.
DENTSPLY Sirona Inc (XRAY) Reddito netto 2024
XRAY l'utile netto (TTM) è stato di -$132.00 milioni per il trimestre terminato il 2023-12-31, un +86.11% aumento anno su anno.
DENTSPLY Sirona Inc (XRAY) Flusso di cassa 2024
XRAY ha registrato un flusso di cassa disponibile (TTM) di $228.00 milioni per il trimestre conclusosi con 2023-12-31, un -38.04% diminuire anno su anno.
DENTSPLY Sirona Inc (XRAY) Utile per azione 2024
L'utile per azione (TTM) di XRAY è stato pari a -$0.62 per il trimestre terminato il 2023-12-31, un +85.97% crescita anno su anno.
DENTSPLY Sirona Inc Azioni (XRAY) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
LUCIER GREGORY T | Director |
Nov 22 '23 |
Buy |
31.44 |
10,000 |
314,400 |
43,121 |
Campion Simon D | President, CEO & Member of BOD |
Nov 20 '23 |
Buy |
29.70 |
10,000 |
297,000 |
243,930 |
Coleman Glenn | Executive VP & CFO |
Nov 20 '23 |
Buy |
29.70 |
10,000 |
297,000 |
73,566 |
BRANDT ERIC | Director |
May 02 '23 |
Option Exercise |
41.47 |
6,200 |
257,114 |
51,102 |
BRANDT ERIC | Director |
May 02 '23 |
Sale |
42.17 |
6,200 |
261,454 |
44,902 |
Capitalizzazione:
|
Volume (24 ore):